The Stroke Care Continuum and Patient Pathway
Volume 4 Issue 1, pages 54-81
Published July 2018
Gregory W Albers
Professor of Neurology and Neurological Sciences, and Director of the Stanford Stroke Center, Stanford University Medical Center, USA.
Markus A Möhlenbruch
Section Chief of Interventional Neuroradiology, Heidelberg University Hospital, Germany.
Director of Clinical Stroke Research and Vice-Chairman Department of Neurology, Universitätsklinikum Essen (AöR), Germany.
Director of Stroke Services, Alfred Health and Adjunct Clinical Professor of Stroke Medicine, Central Clinical School of Monash University, Melbourne, Australia.
Clinical Director. Neuroscience Department, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.
Corresponding Author: Markus A. Möhlenbruch – email@example.com
This article summarizes a Medtronic-sponsored symposium held on May 17th 2018 at the 4th European Stroke Organisation Conference (ESOC) in Gothenburg, Sweden. This symposium was introduced and moderated by Professor Antoni Dávalos. He explained the content of the four speakers’ presentations, collectively, cover important aspects of the total continuum of care and management required for the stroke patient. These presentations covered insights into the acute phase, with a focus on diagnostic imaging methods for the improved selection of those patients with salvageable brain tissue likely to benefit most from endovascular treatment, first year clinical experience and outcomes achieved with with Medtronic’s SolitaireTM Platinum stent-retriever device, secondary prevention considerations, and the importance of identifying patients with or at risk of atrial fibrillation, and finally, the rehabilitation process for disabled stroke patients, highlighting an important potential contribution of intrathecal baclofen therapy (ITB) for poststroke spasticity. Medtronic are committed to improving care and outcomes for stroke patients at all stages of the care continuum in their patient pathway.
Key words: stroke, perfusion imaging, Solitaire PlatinumTM, insertable cardiac monitor, post-stroke spasticity, intrathecal baclofen.
Acknowledgements: The editorial assistance of Mr Rob Goodwin, Oruen Ltd, in the preparation of this article is acknowledged with thanks.